International patent applications for non‐injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the PatentScope database

Publisher： John Wiley & Sons Inc

E-ISSN： 1465-3362|37|2|205-215

ISSN： 0959-5236

Source： DRUG AND ALCOHOL REVIEW, Vol.37, Iss.2, 2018-02, pp. : 205-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is early discharge safe after naloxone reversal of presumed opioid overdose?

By  

Canadian Journal of Emergency Medicine, Vol. 2, Iss. 3, 2000-07 ,pp. : 156-162

Cambridge University Press

Access to resources Recommend Favorite

Patent Watch Patent Searching by the Numbers: Applications to Tissue Engineering

By Dehlinger P.J.  

Biomedical Microdevices, Vol. 2, Iss. 2, 1999-03 ,pp. : 89-90

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities

By Coffin Phillip O.  

Journal of Medical Economics, Vol. 16, Iss. 8, 2013-08 ,pp. : 1051-1060

Informa Healthcare

Access to resources Recommend Favorite

Description of a new non‐injectable connector to reduce the complications of arterial blood sampling

By  

ANAESTHESIA, Vol. 70, Iss. 1, 2015-01 ,pp. : 51-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond

By  

DRUG AND ALCOHOL REVIEW, Vol. 34, Iss. 4, 2015-07 ,pp. : 404-411

John Wiley & Sons Inc

Access to resources Recommend Favorite